MTNB
Matinas Biopharma Hl
Description:
Matinas BioPharma Holdings Inc. (MTNB) is a clinical-stage biopharmaceutical company headquartered in Bedminster, New Jersey, that specializes in innovative oral lipid-based delivery systems aimed at therapeutics for infectious diseases and chronic conditions. The company is committed to enhancing treatment efficacy and patient adherence through its proprietary formulations, addressing significant unmet medical needs in the healthcare sector. With a promising pipeline of candidate products and strategic collaborations, Matinas BioPharma stands out as a compelling investment opportunity for institutional investors looking for advancements in biotechnology that can lead to improved patient outcomes.
Address:
1545 ROUTE 206 SOUTH, BEDMINSTER, NJ, UNITED STATES, 07921
Fiscal year end:
December
Market capitalization:
$4.29 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-99%
How much will you get:
$14
Prices dates:
31-12-2015: $42.50 and 31-12-2025: $0.59